Multimarker Approach to Evaluate the Incidence of the Metabolic Syndrome and Longitudinal Changes in Metabolic Risk Factors — Erik Ingelsson (2007) | RDL Network
Multimarker Approach to Evaluate the Incidence of the Metabolic Syndrome and Longitudinal Changes in Metabolic Risk Factors
Article 2007 en
Authors
EI
Erik Ingelsson
MP
Michael J. Pencina
GT
Geoffrey H. Tofler
Abstract
1 min read
Higher circulating plasminogen activator inhibitor-1 and aldosterone levels are associated with the development of MetS and with longitudinal change of its components, suggesting that these biomarkers and related pathways play a key role in mediating metabolic risk.
Wolfgang Lieb, Martin G. Larson, Emelia Benjamin, Xiaoyan Yin, Geoffrey H. Tofler, Jacob Selhub, Paul F. Jacques, Thomas J. Wang, Joseph A. Vita, Daniel Levy, Ramachandran S. Vasan, Gary F. Mitchell
Caroline S. Fox, Philimon Gona, Martin G. Larson, Jacob Selhub, Geoffrey H. Tofler, Shih-Jen Hwang, James B. Meigs, Daniel Levy, Thomas J. Wang, Paul F. Jacques, Emelia Benjamin, Ramachandran S. Vasan
Lorena Flor da Rosa Franchi Santos, Nicole Perugini Stadtlober, L G Costa Dall'Aqua, Bruna Miglioranza Scavuzzi, Poliana Macedo Guimarães, Tamires Flauzino, Marcell Alysson Batisti Lozovoy, T V Mayumi Iriyoda, Edna Maria Vissoci Reiche, Isaías Dichi, Michael Maes, Andréa Colado Simão
Jacob Joseph, Michael J. Pencina, Thomas J. Wang, Laura J. Hayes, Geoffrey H. Tofler, Paul F. Jacques, Jacob Selhub, Daniel Levy, Ralph B. D’Agostino, Emelia Benjamin, Ramachandran S. Vasan
Discussion(0)
No comments yet. Be the first to comment.